Stem cell growth factor-beta (SCGF-B) activates both granulocyte and macrophage colony-stimulating factor, and SCGF-B, in concert with IL-6, have been implicated in the pathogenesis of obesity-related NAFLD in males (Tarantino et al., 2020). Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.